Javascript must be enabled to continue!
TPO exerts a protective effect on iron-overload induces apoptosis in cardiomyocytes via mitochondrial pathways
View through CrossRef
Thalassaemia companied with iron-overload is common in Hong Kong. Iron overload induced cardiomyopathy is the commonest cause of morbidity and mortality in b-thalassaemia patients. One of the causes of cardiac failure is chronic iron overload of blood transfusion. Some studies showed that iron overload can cause toxic effect in heart cells. Iron-overload induced cardiomyopathy damages are the major complications in patients with beta-thalassaemia major. Iron-overload may induce apoptosis in cardiomyocytes. Our previous study showed TPO has cardiac protective effect (Li et al, Circulation, 2007). In this study, we demonstrated firstly that iron induced oxidative stress can cause apoptosis in cardiomyocytes. By using H9C2 cells, we showed that iron increased reactive oxygen species (ROS) production (n=3) and reduced cell viability in a dose-dependent manner (0-0.6 mM) (n=6). Apoptotic cells were found to be significantly increased under iron treatment (0.3 mM, 72 hrs) in the AnnexinV/PI assay (n=6). The expression of active caspase-3 significantly increased in iron-treated cells. Furthermore, iron treatment increased the proportion of cells containing JC-1 monomers, indicating a trend in the drop of mitochondrial membrane potential (n=6). Secondly, we found that TPO exerted cardio-protective effect on iron-induced apoptosis. H9C2 cells were cultured in the presence of iron (0.3 mM) with or without TPO (50 ng/mL). The ROS production was significantly decreased with the addition of TPO at 50 ng/mL (n=3). Dot-plot analysis of AnnexinV/PI staining demonstrated that TPO significantly reduced the population of apoptotic cells (n=6). Incubation with TPO also decreased the iron-induced caspase-3 expression (n=6). Flow cytometric dot-plot analysis also showed trends of amelioration of the increase in JC-1 monomers in the iron plus TPO group (n=6), indicating a trend in attenuation of the drop of mitochondrial membrane potential. Our findings suggest that iron-overload lead to generation of ROS which further induces apoptosis in cardiomyocytes via mitochondrial pathways and TPO might exert a protective effect on iron-overload induced apoptosis via inhibiting oxidative stress and mitochondrial pathway in cardiomyocytes.
Disclosures:
No relevant conflicts of interest to declare.
Title: TPO exerts a protective effect on iron-overload induces apoptosis in cardiomyocytes via mitochondrial pathways
Description:
Thalassaemia companied with iron-overload is common in Hong Kong.
Iron overload induced cardiomyopathy is the commonest cause of morbidity and mortality in b-thalassaemia patients.
One of the causes of cardiac failure is chronic iron overload of blood transfusion.
Some studies showed that iron overload can cause toxic effect in heart cells.
Iron-overload induced cardiomyopathy damages are the major complications in patients with beta-thalassaemia major.
Iron-overload may induce apoptosis in cardiomyocytes.
Our previous study showed TPO has cardiac protective effect (Li et al, Circulation, 2007).
In this study, we demonstrated firstly that iron induced oxidative stress can cause apoptosis in cardiomyocytes.
By using H9C2 cells, we showed that iron increased reactive oxygen species (ROS) production (n=3) and reduced cell viability in a dose-dependent manner (0-0.
6 mM) (n=6).
Apoptotic cells were found to be significantly increased under iron treatment (0.
3 mM, 72 hrs) in the AnnexinV/PI assay (n=6).
The expression of active caspase-3 significantly increased in iron-treated cells.
Furthermore, iron treatment increased the proportion of cells containing JC-1 monomers, indicating a trend in the drop of mitochondrial membrane potential (n=6).
Secondly, we found that TPO exerted cardio-protective effect on iron-induced apoptosis.
H9C2 cells were cultured in the presence of iron (0.
3 mM) with or without TPO (50 ng/mL).
The ROS production was significantly decreased with the addition of TPO at 50 ng/mL (n=3).
Dot-plot analysis of AnnexinV/PI staining demonstrated that TPO significantly reduced the population of apoptotic cells (n=6).
Incubation with TPO also decreased the iron-induced caspase-3 expression (n=6).
Flow cytometric dot-plot analysis also showed trends of amelioration of the increase in JC-1 monomers in the iron plus TPO group (n=6), indicating a trend in attenuation of the drop of mitochondrial membrane potential.
Our findings suggest that iron-overload lead to generation of ROS which further induces apoptosis in cardiomyocytes via mitochondrial pathways and TPO might exert a protective effect on iron-overload induced apoptosis via inhibiting oxidative stress and mitochondrial pathway in cardiomyocytes.
Disclosures:
No relevant conflicts of interest to declare.
Related Results
5143 Disulfide Bonds of Thyroid Peroxidase Are Critical Elements for Subcellular Localization, Proteasome-Dependent Degradation, and Enzyme Activity
5143 Disulfide Bonds of Thyroid Peroxidase Are Critical Elements for Subcellular Localization, Proteasome-Dependent Degradation, and Enzyme Activity
Abstract
Disclosure: H. Iwasaki: None. H. Suwanai: None. K. Kanekura: None. N. Satoshi: None. F. Yakou: None. H. Sakai: None. K. Ishii: None. N. hara: None. R. Suzuk...
Thrombopoietin Has Protective Effect in Neonatal Hypoxia-Ischemia Rat Model
Thrombopoietin Has Protective Effect in Neonatal Hypoxia-Ischemia Rat Model
Thrombopoietin (TPO) is a growth factor for the megakaryocytic lineage. The expression of TPO and TPO receptor (c-mpl) in the central nervous system (CNS) and the role of TPO in ne...
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rA...
Prevention of Thrombocytopenia by Thrombopoietin in Myelosuppressed Rhesus Monkeys Accompanied by Prominent Erythropoietic Stimulation and Iron Depletion
Prevention of Thrombocytopenia by Thrombopoietin in Myelosuppressed Rhesus Monkeys Accompanied by Prominent Erythropoietic Stimulation and Iron Depletion
Abstract
The effectiveness of thrombopoietin (TPO) in alleviating thrombocytopenia was evaluated in a placebo-controlled study involving rhesus monkeys exposed to 5 ...
Prevention of Thrombocytopenia by Thrombopoietin in Myelosuppressed Rhesus Monkeys Accompanied by Prominent Erythropoietic Stimulation and Iron Depletion
Prevention of Thrombocytopenia by Thrombopoietin in Myelosuppressed Rhesus Monkeys Accompanied by Prominent Erythropoietic Stimulation and Iron Depletion
The effectiveness of thrombopoietin (TPO) in alleviating thrombocytopenia was evaluated in a placebo-controlled study involving rhesus monkeys exposed to 5 Gy total-body irradiatio...
Iron stress affects the survival of Toxoplasma gondii
Iron stress affects the survival of Toxoplasma gondii
Abstract
Background
Iron possesses redox abilities and plays a crucial role in in biosynthesis, energy metabolism, and other biological processes. It represents an indispe...
Metformin inhibits mitochondrial dysfunction and apoptosis in cardiomyocytes induced by high glucose via upregulating AMPK activity
Metformin inhibits mitochondrial dysfunction and apoptosis in cardiomyocytes induced by high glucose via upregulating AMPK activity
Abnormal mitochondrial functions are a major pathophysiological basis of diabetic cardiomyopathy. 5′ AMP-activated protein kinase (AMPK) is involved in mitochondrial dynamics. As a...
PF336 EVALUATION OF THROMBOPOIETIN‐RECEPTOR AGONISTS (TPO‐RAS) «STOP‐THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
PF336 EVALUATION OF THROMBOPOIETIN‐RECEPTOR AGONISTS (TPO‐RAS) «STOP‐THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
Background:For a number of years, it has been shown that TPO‐RAs are a highly effective therapy of ITP. Still, there are few published guidelines/recommendations addressing the man...

